drugset / Trial / NCT06272383

Croup Dosing Study

NCT06272383 ↗

Phase 3 Completed 50 enrolled University of Manitoba
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Croup is a common childhood respiratory disease that often leads to frequent emergency department visits. It is a viral infection that causes cough, throat, and airway swelling, making breathing difficult. Dexamethasone is a medication that helps to reduce swelling, making breathing easier for children. A standard dose of 0.6mg/kg is used in children. However, a lower amount (due to side effects of steroids in children) has been suggested. We will examine whether 25% less than the standard dose is equally effective in treating croup. Investigators will conduct a clinical study with the support of patients with lived experience (which, in this case, are the parents of the children) to better care for children with croup. If proven, this study can improve the outcome in children with croup.

Timeline

Start
2024-06-05
Primary completion
2025-01-28
Completion
2025-02-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule 0.15 mg/kg Oral
Subject Dexamethasone Small molecule 0.6 mg/kg Oral

Indications